Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 839-846

  O'Neill, Michael F ^a   Hicks, Caroline A ^a   Shaw, Gillian ^a   Parameswaran, Tirumaran ^a   Cardwell, Geraldine P ^a   O'Neill, Michael J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; CLOZAPINE; DIZOCILPINE MALEATE; HALOPERIDOL; HEAT SHOCK PROTEIN 70; IMMEDIATE EARLY PROTEIN; KETANSERIN; NEUROLEPTIC AGENT; PROTEIN C FOS; RITANSERIN; SEROTONIN ANTAGONIST; AMESERGIDE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; SEROTONIN RECEPTOR;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; BIOSYNTHESIS; CINGULATE GYRUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOTOR ACTIVITY; MOUSE; ANIMAL TISSUE; BEHAVIOR; GENE EXPRESSION; IMMEDIATE EARLY GENE; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CLOZAPINE; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GYRUS CINGULI; HALOPERIDOL; HSP70 HEAT-SHOCK PROTEINS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; KETANSERIN; MICE; MOTOR ACTIVITY; PROTO-ONCOGENE PROTEINS C-FOS; RITANSERIN; SEROTONIN ANTAGONISTS;

EID: 0032239446     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Behrens B and Gattaz WF (1992) MK-801-induced stereotypies in rats are decreased by haloperidol and increased by diazepam. J Neural Transm 90:219-224.
2. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P. and Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96.
3. Carlsson A (1995) Neurocircuitries and neurotransmitter interactions in schizophrenia. Int Clin Psychopharm 10 Suppl 3:21-28.
4. Carlsson M and Carlsson A (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75:221-226.
5. Clineschmidt BV, Martin GE, Bunting PR and Papp NL (1982) Central sympathomimetic activity ( + )-5-methyl-10,ll-dihydro-5H-dibenzo[a,d]cyclohepten-5,10imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Deu Res 2:135-145.
6. Coccaro EF, Kavoussi RJ, Oakes M, Cooper TB and Hauger R (1996) 5-HT2a/2c receptor blockade by amesergide fully attenuates prolaction response to d-fenfluramine challenge in physically healthy human subjects. Psychopharmacology 126:24-30.
7. Corbett R, Camacho F, Woods AT, Kerman LL, Fishkin RJ, Brooks K and Dünn RW (1995) Antipsychotic agents antagonize noncompetitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology 120:67-74.
8. Farber NB, Foster J, Duham NL and Olney JW (1996) Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity. Schizophrenia Res 21:33-37.
9. Fix AS, Horn JW, Wightman KA, Johnson CA, Long GG, Short, RW, Farber N, Wozniak DF and Olney JW (1993) Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK-801 (di:;ocilpine maleate): A light and electron microscopy evaluation of the rat retrosplenial cortex. Exp Neural 123:204-215.
10. Freed WJ, Weinberger DR, Bing LA and Wyatt RJ (1980) Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimulation in mice. Psychopharmacolcgy 71:291-297.
11. Freed WJ, Bing LA and Wyatt RJ (1984) Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice. Neuropharmacology 23:175-181.
12. Gass P, Herdegen T, Bravo R and Kiessling M (1993) Induction and suppression of immediate early genes in specific rat brain regions by the noncompetitive Nmethyl-D-aspartate receptor antagonist MK-801. Neuroscience 53:749-758.
13. Gleason SD and Shannon H (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79-84.
14. Hiramutsu M, Cho AK and Nabeshima T (1989) Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur J Pharmacol 166:359-366.
15. Hitri A, O'Connor DA, Cohen JM, Keuler DJ and Deutsch SI (1993) Differentiation between MK-801- and apomorphine-induced stereotyped behaviors in mice. Can Neuropharmacol 16:220-236.
16. Hoffman DC (1992) Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats. J Neural Transtn 89:1-10.
17. Hoyer D (1991) 5-Hydroxytrytophan receptors and effector coupling mechanisms in peripheral tissues. In The Peripheral Actions of 5-Hydroxytryptamine, ed. by J. Fozard, pp 72-99, Oxford, Oxford University Press.
18. Javitt DC and Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
19. Kinon BJ and Lieberman JA (1996) Mechanisms of action of atypical antipsychotic drugs: A critical analysis. Psychopharmacology 124:2-34.
20. Kurumaji A and McCulloch J (1989) Effects of MK-801 upon local cerebral glucc.se utilisation in concious and in rats anaesthetised with halothane. J Cereb Blood Flow Metab 9:786-794
21. Kurumaji A, Nehls DG, Park CK and McCulloch J (1989) Effects of NMDA antago-nists, MK-801 and CPP, upon local cerebral glucose use. Brain. Res 496:268-284.
22. Liljequist S, Ossowska K, Grabowska-Anden M. and Anden N-E (1991) Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol 195:55-61.
23. Lodge D and Johnson KM (1990) Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sei 11:81-86.
24. Maurel-Remy S, Bervoets K and Millan MJ (1995) Blockade of phencyclidineinduced hyper-locomotion by MDL100.907 in rats reflects antagonism of 5-HT2A receptors. Eur J Pharmacol. 280:R9-R11.
25. Nabeshima T, Ishikawa K, Yamaguchi K, Furukawa H and Kameyama T (1987) Phencyclidine-induced head-weaving observed in mice after ritanserin treatment. Eur J Pharmacol 139:171-178.
26. Näkki R, Nickolenko J, Chang J, Sagar SM and Sharp FR (1996) Haloperidol prevents ketamine- and phencyclidine-induced hsp-70 protein expression but not microglial activation. Exp Neural 137:234-241.
27. Ogren SO and Goldstein M (1994) Phencyclidine and dizocilpine-induced hyperlomotion are differentially mediated. Neuropsychopharmacology 11:167-177.
28. Olney JW, Labuyere J and Price MT (1989) Pathological changes induced in ce:-ebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362.
29. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT and Sesma MA (1991) NMDA antagonist neurotoxicity: Mechanism and prevention. Science 254:1515-1518.
30. Ouagazzal A, Nieoullon A and Amalric M (1993) Effects of dopamine Dl and 132 receptor blockade on MK-801-induced hyperlocomotion in rats. Pyschopharmacilogy 111:427-434.
31. Sagar SM, Sharp FR and Curran T (1988) Expression of c-fos in brain: Metabolic mapping at the cellular level. Science 240:1328-1331.
32. Schmidt CJ and Fayadel GM (1996) Regional effects of MK-801 on dopamine release: Effects of competitive NMDA or 5-HT2A receptor blockade. J Pharmacol Exp Tter 277:1541-1549.
33. Sharp FR, Jasper P, Hall J, Noble L and Sagar SM (1991) MK-801 and ketamine induce heat shock protein hsp70 in injured neurons in posterior cingulate and retrosplenial cortex. Ann Neural 30:801-809.
34. Sharp FR, Butman M, Aardalen K, Nickolenko J, Näkki R, Massa SM, Swanson IIA and Sagar SM (1994) Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics. P:tychopharmacol Bull 30: 555-560.
35. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada 0 and Shmohara M (1977) The [I4C]deoxyglucose method for the mea-surement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anaesthetized albino rat. J Neurochem 28:897-91fi.
36. Stefansky R and Goldberg SR (1997) Serotonin 5-HT2 receptor antagonists: Poten-tial in the treatment of psychiatric disorders. CNS Drugs 7:388-409.
37. Vass K, Welch WJ and Nowak TS Jr (1988) Localization of 70kD stess protein induction in gerbil brain after ischemia. Ada Neuropathol 77:128-135.
38. Vass K, Berger ML, Nowak TS Jr, Welch WJ and Lassmann H (1989) Induction of stress protein hsp-70 in nerve cells after status epilepticus in the rat. Neurosci L?tt 100:259-264.
39. Verma A and Kulkarni SK (1992) Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology 107:431-436.
40. Wong EHF, Kemp JA, Priestly T, Knight AR, Woodruff GN and Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sei USA 83:7104-7108.